Trivrit: Benefits, Evidence, Dosage & Safety

TL;DR

Trivrit (Operculina turpethum) is Ayurveda's purgative, ranked among the best mild laxatives (sukhavirechana) in classical texts. Its only controlled trial: 90 patients, where 5 g of root-bark powder daily for 3 days gave mild improvement in 70%, best of the three herbs tested. As a purgative, overuse risks dehydration and electrolyte imbalance: avoid in pregnancy; use under practitioner guidance.

What it is

Trivrit (Operculina turpethum (L.) Silva Manso) is a perennial climbing herb of the morning-glory family (Convolvulaceae), with milky juice and vines several meters long; the root and root bark are the medicinal parts (PMC review). It is known in English as Indian jalap. Its purgative action comes from turpethin, a glycosidic resin that makes up roughly 10% of the root bark's resin, related to jalapin and convolvulin: along with turpethinic acids A–E, scopoletin, and beta-sitosterol (PMC review; AJPCR phytochemical paper).

Classical texts distinguish two varieties: the white variety, which is used medicinally, and the black (shyama) variety, which is considered a drastic purgative with emetic effects and is not regarded as therapeutically safe (Unani-system review).

Traditional use

Trivrit is one of Ayurveda's oldest purgatives. Charaka places it in the Bhedaniya Mahakashaya (the group of purgative drugs), and Sushruta lists it in the Shyamadi Gana as an adhobhagahara (downward-cleansing) drug (literary review, IJSR). Classical texts rank it as the best drug among sukhavirechana: the mild, comfortable laxatives (Journal of Research in Ayurvedic Sciences).

In Ayurvedic pharmacology it is described (with minor variation across nighantus) as katu-tikta rasa, ruksha guna, ushna virya, and katu vipaka, pacifying Kapha and Pitta (IJSR literary review). It is the purgative of choice in virechana, the therapeutic purgation procedure of Panchakarma, and is used for purishaja anaha (constipation), as well as in compound formulations such as Avipattikara churna for hyperacidity and gastric complaints (AJPCR paper). These are traditional claims, not clinical proof: the human evidence is assessed separately below.

What modern research says

Constipation (double-blind comparative study)

The only modern human study is a randomized, comparative, double-blind trial published in the Journal of Research in Ayurvedic Sciences: 90 patients with purishaja anaha (constipation) were divided into three equal groups receiving 5 g of root-bark powder daily for 3 days, Operculina turpethum, Marsdenia tenacissima, or Operculina petaloidea, with follow-up at 7 days. Mild improvement was seen in 70% of the O. turpethum group, and both Operculina species showed a better purgative effect than M. tenacissima; overall, O. turpethum performed best across the studied parameters (JRAS).

Limitations are substantial: three days of treatment, seven days of follow-up, no placebo group, 30 patients per arm, and the full paper is paywalled, so the analysis rests on the published abstract. It shows trivrit can produce a mild laxative effect over a short course, which is what a purgative is supposed to do, not that it is a safe or effective long-term treatment for constipation.

Toxicity (animal studies only)

Acute toxicity work in animals has not shown alarming signals at tested doses: an ethanolic extract produced no changes in liver-function markers (SGOT, SGPT, bilirubin, alkaline phosphatase) in rats, and a root suspension at 10–800 mg/kg caused no toxic action in mice over a week (reviewed in PMC5628523). The reported oral LD50 of a methanolic extract in mice was 1,917.66 mg/kg (same review). Animal toxicity data do not establish human safety.

Evidence gaps

A 2017 comprehensive review concluded that, apart from a few small uncontrolled reports (rheumatoid arthritis, ascariasis), no randomized, placebo-controlled clinical trials of trivrit had been performed, and called for proper RCTs to confirm effectiveness and safety (PMC review). The JRAS comparative study above postdates that review and remains the only controlled human study: still without a placebo arm.

What the evidence does not support (yet)

Long-term use for chronic constipation, detox or "cleansing" claims beyond its purgative action, and any of its other traditional indications (skin disease, worms, abdominal lumps) in humans.

Dosage

The only human regimen comes from the JRAS trial: 5 g of root-bark powder per day for 3 days: a short research course in a supervised study, not a personal recommendation (JRAS). Classical literature reports root powder at 1–3 g (IJSR literary review). Trivrit is a purgative properly used within supervised virechana procedures; do not self-prescribe doses or durations.

Safety & contraindications

Read this section fully: trivrit is a purgative, and purgatives injure when misused. Diarrhea and abdominal cramping are the expected effects; with overuse, fluid loss and electrolyte imbalance can follow. No human study has measured these risks: the cautions below are precautionary, drawn from its purgative pharmacology and classical restrictions, not from clinical evidence.

FAQs

What is trivrit used for in Ayurveda?

Primarily as a purgative: it is the classic drug for virechana (therapeutic purgation in Panchakarma) and for constipation (purishaja anaha), and it appears in formulations like Avipattikara churna for hyperacidity (AJPCR paper). Traditional use is not clinical proof.

How does trivrit work?

Its purgative action is attributed to turpethin, a glycosidic resin in the root bark (about 10% of the resin) related to the purgative resins jalapin and convolvulin (PMC review).

Is trivrit safe for daily or long-term use?

No. It is a purgative, not a daily tonic: prolonged use would be expected to risk dehydration and electrolyte imbalance. Classical use is short-course and typically within supervised virechana. There are no human data supporting chronic use.

Can I take trivrit during pregnancy?

Avoid it. Strong purgatives are classically restricted in pregnancy, and there are no modern human safety data. Use only if an Ayurvedic practitioner specifically directs it.

What happens if I take too much?

Expect severe diarrhea and abdominal cramps, with risk of dehydration and electrolyte loss: no human overdose data exist. Stop the herb, rehydrate, and seek medical care if symptoms are significant or prolonged.

Which variety of trivrit is used - white or black?

The white variety is the medicinal one. The black (shyama) variety is classically considered a drastic purgative with emetic effects and is not regarded as therapeutically safe (Unani-system review).

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.